These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 27267001

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
    Chen H, Zhang X, Zhang X, Fan Z, Liu W, Lei Y, Zhu C, Ma B.
    Bioorg Med Chem; 2020 Oct 15; 28(20):115699. PubMed ID: 33069078
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.
    Hao X, Han Z, Li Y, Li C, Wang X, Zhang X, Yang Q, Ma B, Zhu C.
    Bioorg Med Chem Lett; 2017 Feb 15; 27(4):887-892. PubMed ID: 28109789
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pyridothiadiazine derivatives as aldose reductase inhibitors having antioxidant activity.
    Zhu S, Zhang S, Hao X, Qin X, Parveen S, Yang S, Ma B, Zhu C.
    J Enzyme Inhib Med Chem; 2016 Feb 15; 31(sup1):126-130. PubMed ID: 27153454
    [Abstract] [Full Text] [Related]

  • 10. Phenolic 4-hydroxy and 3,5-dihydroxy derivatives of 3-phenoxyquinoxalin-2(1H)-one as potent aldose reductase inhibitors with antioxidant activity.
    Zou Y, Qin X, Hao X, Zhang W, Yang S, Yang Y, Han Z, Ma B, Zhu C.
    Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3924-7. PubMed ID: 26227780
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.
    Chen X, Yang Y, Ma B, Zhang S, He M, Gui D, Hussain S, Jing C, Zhu C, Yu Q, Liu Y.
    Eur J Med Chem; 2011 May 15; 46(5):1536-44. PubMed ID: 21367494
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A, Tehseen Y, Khan I, Hameed A, Saeed A, Furtmann N, Bajorath J, Iqbal J.
    Bioorg Chem; 2016 Oct 15; 68():177-86. PubMed ID: 27544072
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications.
    Ottanà R, Maccari R, Giglio M, Del Corso A, Cappiello M, Mura U, Cosconati S, Marinelli L, Novellino E, Sartini S, La Motta C, Da Settimo F.
    Eur J Med Chem; 2011 Jul 15; 46(7):2797-806. PubMed ID: 21531055
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.